Children's cancers, Neuroblastoma
Results
Phase 1
This trial looked at a drug called ribociclib as treatment for neuroblastoma and a rare type of childhood cancer called a malignant rhabdoid tumour.
Recruitment start: 1 August 2013
Recruitment end: 28 February 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Pearson
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 02 Apr 2019
CRUK internal database number: 11138